AIMD Stock Summary and Trading Ideas (Ainos | NASDAQ:AIMD)

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Ainos trades on the NASDAQ stock market under the symbol AIMD.

As of October 16, 2026, AIMD stock price declined to $0.92 with 14,285 million shares trading.

AIMD has a beta of 3.62, meaning it tends to be more sensitive to market movements. AIMD has a correlation of 0.23 to the broad based SPY ETF.

AIMD has a market cap of $6.82 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, AIMD traded as high as $21.45 and as low as $.87.

The top ETF exchange traded funds that AIMD belongs to (by Net Assets): VXF.

AIMD has underperformed the market in the last year with a price return of -77.1% while the SPY ETF gained +16.7%. AIMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -45.7% and -31.7%, respectively, while the SPY returned +1.9% and -0.8%, respectively.

AIMD support price is $.89 and resistance is $1.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AIMD shares will trade within this expected range on the day.